載脂蛋白M(APOM)重組蛋白
Recombinant Apolipoprotein M (APOM)
Apo-M; G3a; NG20; Protein G3a
- 編號(hào)RPC299Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量27.0kDa
- 實(shí)際分子量28kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Ala8~Asn188 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)5.7
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 840¥ 2100¥ 4200¥ 12600¥ 31500
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC299Hu01 | 載脂蛋白M(APOM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC299Hu01 | 載脂蛋白M(APOM)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC299Hu71 | 載脂蛋白M(APOM)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAC299Hu81 | 載脂蛋白M(APOM)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAC299Hu21 | 載脂蛋白M(APOM)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC299Hu22 | 載脂蛋白M(APOM)單克隆抗體 | WB; IHC; ICC; IP. |
| SEC299Hu | 載脂蛋白M(APOM)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| HEC299Hu | 載脂蛋白M(APOM)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC299Hu | 載脂蛋白M(APOM)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Joint Bone Spine | Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk ofrheumatoid arthritis[Pubmed: 23660425] |
| Apoptosis | The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis[PubMed: 26201458] |
| Lipids in Health and Disease | Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case–control study[pubmed:27633510] |
| Lipids in Health and Disease | A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus[pubmed:27576735] |
| clinica chimica acta | ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.[pubmed:28073663] |
| International Journal of Clinical and Experimental Pathology | Level of serum apolipoprotein m and its diagnostic significance in inflammatory bowel disease[files:ijcep0033416.pdf] |
| Scandinavian Journal of Medicine &?Science?in?Sports | Endurance training selectively increases HDL-bound sphingosine-1-phosphate in the plasma [pubmed:28493600] |
| INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | HDL-S1P Protects Endothelial Function and Reduces Lung Injury During Sepsis in vivo and in vitro[Pubmed: 32750426] |
| Biology-Basel | Biomechanical Properties of Blood Plasma Extracellular Vesicles Revealed by Atomic Force Microscopy[33374530] |
| researchsquare | Apolipoprotein M in High Density Lipoprotein Protects Against Astrocyte Apoptosis Induced By Ischemic Insult Via Sphingosine 1-Phosphate Signaling[] |